| Microstructures and mechanical properties of electron beam-rapid manufactured Ti–6Al–4V biomedical prototypes compared to wrought Ti–6Al–4V LE Murr, EV Esquivel, SA Quinones, SM Gaytan, MI Lopez, EY Martinez, ... Materials characterization 60 (2), 96-105, 2009 | 660 | 2009 |
| Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease M Delgado, C Abad, C Martinez, J Leceta, RP Gomariz Nature medicine 7 (5), 563-568, 2001 | 455 | 2001 |
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ... Gastroenterology 124 (4), 961-971, 2003 | 285 | 2003 |
| Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6 M Delgado, C Martinez, D Pozo, JR Calvo, J Leceta, D Ganea, ... The Journal of Immunology 162 (2), 1200-1205, 1999 | 231 | 1999 |
| Immunology of VIP: a review and therapeutical perspectives RP Gomariz, C Martinez, C Abad, J Leceta, M Delgado Current pharmaceutical design 7 (2), 89-111, 2001 | 206 | 2001 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies M Delgado, D Pozo, C Martinez, J Leceta, JR Calvo, D Ganea, ... The Journal of Immunology 162 (4), 2358-2367, 1999 | 205 | 1999 |
| Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ... Journal of molecular medicine 80, 16-24, 2002 | 204 | 2002 |
| Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi JJ Cazzulo, MCC Franke, J Martínez, BMF de Cazzulo Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 1990 | 182 | 1990 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages C Martínez, M Delgado, D Pozo, J Leceta, JR Calvo, D Ganea, ... Journal of leukocyte biology 63 (5), 591-601, 1998 | 180 | 1998 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia M Delgado, J Leceta, D Ganea Journal of Leucocyte Biology 73 (1), 155-164, 2003 | 161 | 2003 |
| VIP–PACAP system in immunity: new insights for multitarget therapy RP Gomariz, Y Juarranz, C ABAD, A Arranz, J Leceta, C Martinez Annals of the New York Academy of Sciences 1070 (1), 51-74, 2006 | 158 | 2006 |
| Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ... Arthritis research & therapy 7, 1-12, 2005 | 158 | 2005 |
| PACAP in immunity and inflammation M Delgado, C Abad, C Martinez, MG Juarranz, J Leceta, D Ganea, ... Annals of the New York Academy of Sciences 992 (1), 141-157, 2003 | 152 | 2003 |
| Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor C Martinez, C Abad, M Delgado, A Arranz, MG Juarranz, ... Proceedings of the National Academy of Sciences 99 (2), 1053-1058, 2002 | 151 | 2002 |
| Cindy Sherman: the complete untitled film stills C Sherman The Museum of Modern Art, 2003 | 150* | 2003 |
| Immunobiology of vasoactive intestinal peptide (VIP) D Pozo, M Delgado, C Martı́nez, JM Guerrero, J Leceta, RP Gomariz, ... Immunology today 21 (1), 7-11, 2000 | 143 | 2000 |
| Regulation of VIP production and secretion by murine lymphocytes C Martinez, M Delgado, C Abad, RP Gomariz, D Ganea, J Leceta Journal of neuroimmunology 93 (1-2), 126-138, 1999 | 140 | 1999 |
| Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi BM Franke de Cazzulo, J Martínez, MJ North, GH Coombs, JJ Cazzulo FEMS microbiology letters 124 (1), 81-86, 1994 | 133 | 1994 |
| VALIDEZ DE 6 METODOS INDIRECTOS PARA VALORAR EL CUMPLIMIENTO TERAPEUTICO EN HIPETENSION ARTERIAL V Gil, M Pineda, JL Martínez, J Belda, ML Santos, J Merino Medicina clínica 102 (14), 532-536, 1994 | 115 | 1994 |
| Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis YV Tan, C Abad, R Lopez, H Dong, S Liu, A Lee, RP Gomariz, J Leceta, ... Proceedings of the National Academy of Sciences 106 (6), 2012-2017, 2009 | 113 | 2009 |
